Corporate

Award Funding Extends Company’s Ongoing Commitment to Supporting Underserved Communities in the United States

A Johnson & Johnson Health and Wellness Solutions study shows managing mental wellness is critical to improve quality of life in patients with chronic illness

A New Commitment to 2030 Sustainable Development Goals and Ongoing Support for Refugees

Acquisition to Strengthen Global Leadership in Eye Health Adding Cataract and Refractive Eye Surgery to Vision Care Portfolio

Johnson & Johnson (NYSE: JNJ) today announced that the District of Massachusetts Federal Court has issued a ruling on a summary judgment motion filed by Celltrion Healthcare Co. Ltd. and Celltrion Inc

Acquisition Strengthens Position in Hair Care

Largest QuickFire competition to date will award up to $500,000 in a research grant and entrance to Johnson & Johnson Innovation, JLABS, to promising transformational healthcare solution Challenge launched at 2016 BIO International Convention during the Bionic Innovation Forum

As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.

$1,000,000 program funded by Johnson & Johnson will be the first to help nurses specialize in cystic fibrosis education